Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00860
|
|||||
| Drug Name |
N6-cyclopentyladenosine
|
|||||
| Synonyms |
(2R,3R,4S,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; (2R,3R,4S,5R)-2-[6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol; 41552-82-3; 7LG47VG1ID; AC1LCWG1; Adenosine, N-cyclopentyl-; CHEMBL68738; Cyclopentyladenosine; GTPL380; MLS000028368; MLS001077332; MLS002153196; N(6)-Cyclopentyladenosine; N6-CyclopentylAdo; N6-Cyclopentyladenosine; Opera_ID_1056; SCHEMBL120481; SMR000058639; UNII-7LG47VG1ID; n-cyclopentyl-adenosine; n-cyclopentyladenosine; n6-cyclopentyl-adenosine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H21N5O4
|
|||||
| Canonical SMILES |
C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O
|
|||||
| InChI |
InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1
|
|||||
| InChIKey |
SQMWSBKSHWARHU-SDBHATRESA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 335.36 | Topological Polar Surface Area | 126 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
0.9
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.